MYLAN-EFAVIRENZ
MYLAN-EFAVIRENZ
Approved
DIN Number
02381524
Drug Class
Human
Market Date
Jul 30, 2013
Company
HC
Mylan Pharmaceuticals ULC
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02381524
AIG Number0137031005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AG03 EFAVIRENZ
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:18.08.16
Health Canada Classification
ACTIVE INGREDIENTS (1)
EFAVIRENZActive
Strength: 600 MG
Monograph: EFAVIRENZ